Skip to Content

Zimmer Biomet Holdings, Inc.

Securities Class Action

  • Date:
  • 11/20/2025
  • Company Name:
  • Zimmer Biomet Holdings, Inc.
  • Stock Symbol:
  • ZBH
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zimmer Biomet Holdings, Inc.  (“Zimmer Biomet” or the “Company”) (exchange: ticker) on behalf of Zimmer Biomet stockholders. Our investigation concerns whether Zimmer Biomet has violated the federal securities laws and/or engaged in other unlawful business practices.
 

On November 5, 2025, Zimmer Biomet issued a press release announcing its financial results for the third quarter of 2025 and held an earnings call to discuss the same. Among other items, Zimmer Biomet reported net sales of $2 billion, missing consensus estimates of $2.01 billion. Zimmer Biomet also lowered the top end of its outlook for full-year organic revenue growth, projecting gains of 3.5% to 4%, compared to a previous range of 3.5% to 4.5%. Zimmer Biomet reported weakness in international markets and non-core businesses, while its Chief Executive Officer said that distributor challenged and a cancelation of orders in the Middle East and Eastern Europe also weighed on the Company's results. Analysts also noted lower-than-expected growth in U.S. knee and hip replacement sales, expressing concerns about Zimmer Biomet's operational controls. 

On this news, Zimmer Biomet's stock price fell $15.63 per share, or 15.5%, to close at $87.55 per share on November 5, 2025.


If you purchased or otherwise acquired Zimmer Biomet shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.

Contact Instructions
Please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com with any questions regarding the case. 
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Zimmer Biomet Holdings. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: